About Index Trending news
Analyze
Pricing
Vivo Capital

Vivo Capital

Work at Vivo Capital? Add yourself to this profile

Vivo Capital

Elsewhere

Alexa global traffic share

Investment profile

Target markets
Health Care Biotechnology

Activity

Past year's investments

- Vivo Capital participated in 10 rounds in the past year.
- The total disclosed amount of capital deployed in those rounds was $365,500,000 (averaging $36,550,000 per round).

Latest rounds

- Homology Medicines: Venture capital (Series B) ($83.5M)
- Menlo Therapeutics: Venture capital (Series C) ($50M)
- Zai Lab: Venture capital (Series C) ($30M)

Main Co-investors

- Rock Springs Capital
- RA Capital Management
- OrbiMed

Total funding
$109.2M in 4 rounds from 23 investors
By Vivo Capital
$68M Series C in Apr, 2016
Total funding
$61M in 2 rounds from 10 investors
By Vivo Capital
$35M Series D in Sep, 2016
Total funding
$130M in 2 rounds from 9 investors
By Vivo Capital
$30M Series C in Jun, 2017
Total funding
$40.3M in 5 rounds from 7 investors
By Vivo Capital
$36M Series C in Dec, 2016
Total funding
$41M in 1 rounds from 5 investors
By Vivo Capital
$41M Series A in Mar, 2016
Total funding
$127M in 2 rounds from 17 investors
By Vivo Capital
$83.5M Series B in Aug, 2017
Total funding
$55M in 1 rounds from 5 investors
By Vivo Capital
$55M Series C in Jul, 2016
Total funding
$18M in 1 rounds from 5 investors
By Vivo Capital
$18M Series A in Sep, 2016
Total funding
$25.5M in 2 rounds from 5 investors
By Vivo Capital
$23M Series A in Sep, 2016
Total funding
$60M in 1 rounds from 6 investors
By Vivo Capital
$60M Series D in Dec, 2014
Total funding
$100M in 2 rounds from 13 investors
By Vivo Capital
$80M Venture Capital in Nov, 2016
Total funding
An undisclosed amount in 1 rounds from 9 investors
By Vivo Capital
undisclosed deal in Mar, 2017
Total funding
$10M in 1 rounds from 5 investors
By Vivo Capital
$10M Series A in Jun, 2017
Total funding
$50M in 1 rounds from 9 investors
By Vivo Capital
$50M Series C in Jul, 2017

Want to see the complete list?
Go Pro!